• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宏基因组学和代谢组学分析揭示慢性心力衰竭患者肠道微生物群落失调。

Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients.

机构信息

Fuwai Hospital, State Key Laboratory of Cardiovascular Diseases, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100037, P.R. China.

Novogene Bioinformatics Institute, Beijing, 100000, P.R. China.

出版信息

Sci Rep. 2018 Jan 12;8(1):635. doi: 10.1038/s41598-017-18756-2.

DOI:10.1038/s41598-017-18756-2
PMID:29330424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5766622/
Abstract

Previous studies suggested a possible gut microbiota dysbiosis in chronic heart failure (CHF). However, direct evidence was lacking. In this study, we investigated the composition and metabolic patterns of gut microbiota in CHF patients to provide direct evidence and comprehensive understanding of gut microbiota dysbiosis in CHF. We enrolled 53 CHF patients and 41 controls. Metagenomic analyses of faecal samples and metabolomic analyses of faecal and plasma samples were then performed. We found that the composition of gut microbiota in CHF was significantly different from controls. Faecalibacterium prausnitzii decrease and Ruminococcus gnavus increase were the essential characteristics in CHF patients' gut microbiota. We also observed an imbalance of gut microbes involved in the metabolism of protective metabolites such as butyrate and harmful metabolites such as trimethylamine N-oxide in CHF patients. Metabolic features of both faecal and plasma samples from CHF patients also significantly changed. Moreover, alterations in faecal and plasma metabolic patterns correlated with gut microbiota dysbiosis in CHF. Taken together, we found that CHF was associated with distinct gut microbiota dysbiosis and pinpointed the specific core bacteria imbalance in CHF, along with correlations between changes in certain metabolites and gut microbes.

摘要

先前的研究表明,慢性心力衰竭(CHF)患者可能存在肠道微生物群落失调。然而,这方面直接证据的缺乏。在这项研究中,我们调查了 CHF 患者肠道微生物群落的组成和代谢模式,为 CHF 患者肠道微生物群落失调提供了直接证据和全面的认识。我们纳入了 53 名 CHF 患者和 41 名对照者。然后对粪便样本进行宏基因组学分析,对粪便和血浆样本进行代谢组学分析。我们发现 CHF 患者肠道微生物群落的组成与对照者有显著差异。Faecalibacterium prausnitzii 的减少和 Ruminococcus gnavus 的增加是 CHF 患者肠道微生物群落的主要特征。我们还观察到 CHF 患者涉及保护性代谢物(如丁酸)和有害代谢物(如三甲胺 N-氧化物)代谢的肠道微生物失衡。CHF 患者粪便和血浆样本的代谢特征也明显改变。此外,粪便和血浆代谢模式的改变与 CHF 患者肠道微生物群落失调相关。总之,我们发现 CHF 与明显的肠道微生物群落失调有关,并确定了 CHF 中特定的核心细菌失衡,以及某些代谢物和肠道微生物之间的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/9154746dd6da/41598_2017_18756_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/6acb072e8f6e/41598_2017_18756_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/dce3fad87f61/41598_2017_18756_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/7725d2878576/41598_2017_18756_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/b83cd5291180/41598_2017_18756_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/ec54eee318fd/41598_2017_18756_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/8b3ce7f59cde/41598_2017_18756_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/9154746dd6da/41598_2017_18756_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/6acb072e8f6e/41598_2017_18756_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/dce3fad87f61/41598_2017_18756_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/7725d2878576/41598_2017_18756_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/b83cd5291180/41598_2017_18756_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/ec54eee318fd/41598_2017_18756_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/8b3ce7f59cde/41598_2017_18756_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eff/5766622/9154746dd6da/41598_2017_18756_Fig7_HTML.jpg

相似文献

1
Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients.宏基因组学和代谢组学分析揭示慢性心力衰竭患者肠道微生物群落失调。
Sci Rep. 2018 Jan 12;8(1):635. doi: 10.1038/s41598-017-18756-2.
2
Different Types of Atrial Fibrillation Share Patterns of Gut Microbiota Dysbiosis.不同类型的心房颤动存在肠道微生物失调的模式。
mSphere. 2020 Mar 18;5(2):e00071-20. doi: 10.1128/mSphere.00071-20.
3
Gut microbiome and metabolome to discover pathogenic bacteria and probiotics in ankylosing spondylitis.研究肠微生物组和代谢组,以发现强直性脊柱炎中的致病菌和益生菌。
Front Immunol. 2024 Apr 22;15:1369116. doi: 10.3389/fimmu.2024.1369116. eCollection 2024.
4
Metagenomics and Faecal Metabolomics Integrative Analysis towards the Impaired Glucose Regulation and Type 2 Diabetes in Uyghur-Related Omics.基于宏基因组学和粪便代谢组学的维吾尔族相关组学中葡萄糖调节受损和 2 型糖尿病的综合分析
J Diabetes Res. 2019 Nov 18;2019:2893041. doi: 10.1155/2019/2893041. eCollection 2019.
5
Gut microbiota signatures in cystic fibrosis: Loss of host CFTR function drives the microbiota enterophenotype.囊性纤维化中的肠道微生物组特征:宿主 CFTR 功能丧失导致微生物组肠病表型。
PLoS One. 2018 Dec 6;13(12):e0208171. doi: 10.1371/journal.pone.0208171. eCollection 2018.
6
Gut microbiota composition and butyrate production in children affected by non-IgE-mediated cow's milk allergy.非 IgE 介导的牛奶过敏儿童的肠道微生物组成和丁酸产生。
Sci Rep. 2018 Aug 21;8(1):12500. doi: 10.1038/s41598-018-30428-3.
7
Urinary and Fecal Metabonomics Study of the Protective Effect of Chaihu-Shu-Gan-San on Antibiotic-Induced Gut Microbiota Dysbiosis in Rats.柴胡疏肝散对抗生素诱导大鼠肠道菌群失调的尿粪代谢组学研究。
Sci Rep. 2017 Apr 20;7:46551. doi: 10.1038/srep46551.
8
Altered gut microbiota in Rett syndrome.雷特综合征中的肠道微生物组改变。
Microbiome. 2016 Jul 30;4(1):41. doi: 10.1186/s40168-016-0185-y.
9
Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.肾功能受损和肠道微生物群落失调导致慢性肾脏病患者中三甲胺-N-氧化物水平升高。
Sci Rep. 2017 May 3;7(1):1445. doi: 10.1038/s41598-017-01387-y.
10
Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis.特应性皮炎患者肠道微生物组中普拉梭菌亚种水平失调。
J Allergy Clin Immunol. 2016 Mar;137(3):852-60. doi: 10.1016/j.jaci.2015.08.021. Epub 2015 Oct 1.

引用本文的文献

1
From Gut Inflammation to Cardiovascular Conflagration: Mapping IBD's Cardiometabolic Risks.从肠道炎症到心血管“战火”:梳理炎症性肠病的心血管代谢风险
Curr Atheroscler Rep. 2025 Sep 10;27(1):89. doi: 10.1007/s11883-025-01329-4.
2
Role of gut microbiota and derived metabolites in cardiovascular diseases.肠道微生物群及其衍生代谢产物在心血管疾病中的作用。
iScience. 2025 Jul 30;28(9):113247. doi: 10.1016/j.isci.2025.113247. eCollection 2025 Sep 19.
3
Arterial stiffness and vascular aging: mechanisms, prevention, and therapy.动脉僵硬度与血管衰老:机制、预防及治疗

本文引用的文献

1
Dysbiosis and compositional alterations with aging in the gut microbiota of patients with heart failure.心力衰竭患者肠道微生物群随衰老出现的生态失调和组成改变。
PLoS One. 2017 Mar 22;12(3):e0174099. doi: 10.1371/journal.pone.0174099. eCollection 2017.
2
Gut microbiota dysbiosis contributes to the development of hypertension.肠道微生物失调与高血压的发生发展有关。
Microbiome. 2017 Feb 1;5(1):14. doi: 10.1186/s40168-016-0222-x.
3
High-Fiber Diet and Acetate Supplementation Change the Gut Microbiota and Prevent the Development of Hypertension and Heart Failure in Hypertensive Mice.
Signal Transduct Target Ther. 2025 Sep 1;10(1):282. doi: 10.1038/s41392-025-02346-0.
4
Microbial Metabolites and Cardiovascular Dysfunction: A New Era of Diagnostics and Therapy.微生物代谢产物与心血管功能障碍:诊断与治疗的新时代。
Cells. 2025 Aug 11;14(16):1237. doi: 10.3390/cells14161237.
5
Microbiome and cardiovascular health unexplored frontiers in precision cardiology: a narrative review.微生物群与心血管健康:精准心脏病学中未被探索的前沿领域:一篇综述。
Ann Med Surg (Lond). 2025 May 26;87(7):4255-4261. doi: 10.1097/MS9.0000000000003430. eCollection 2025 Jul.
6
Novel opportunity of treatment for psycho-cardiologic disease by gut microbiome.肠道微生物群为心理心脏病学疾病提供的新型治疗机会。
Front Cardiovasc Med. 2025 Jul 22;12:1604962. doi: 10.3389/fcvm.2025.1604962. eCollection 2025.
7
Preliminary Study to Understand the Role of Gut Microbiota in Coronary Slow Flow Phenomenon (CSFP).了解肠道微生物群在冠状动脉慢血流现象(CSFP)中作用的初步研究。
Metabolites. 2025 Jul 14;15(7):475. doi: 10.3390/metabo15070475.
8
Interactions between gut microbiota and cardiovascular drugs: effects on drug therapeutic effect and side effect.肠道微生物群与心血管药物之间的相互作用:对药物治疗效果和副作用的影响。
Front Cardiovasc Med. 2025 Jul 10;12:1570008. doi: 10.3389/fcvm.2025.1570008. eCollection 2025.
9
Gut microbiota dysbiosis exacerbates heart failure by the LPS-TLR4/NF-κB signalling axis: mechanistic insights and therapeutic potential of TLR4 inhibition.肠道微生物群失调通过LPS-TLR4/NF-κB信号轴加重心力衰竭:TLR4抑制的机制见解和治疗潜力
J Transl Med. 2025 Jul 10;23(1):762. doi: 10.1186/s12967-025-06821-8.
10
The role of the gut microbiota and its metabolites: a new predictor in diabetes and its complications.肠道微生物群及其代谢产物的作用:糖尿病及其并发症的新预测指标。
Eur J Med Res. 2025 Jul 9;30(1):601. doi: 10.1186/s40001-025-02824-9.
高纤维饮食和乙酸盐补充改变肠道微生物群,预防高血压小鼠高血压和心力衰竭的发生。
Circulation. 2017 Mar 7;135(10):964-977. doi: 10.1161/CIRCULATIONAHA.116.024545. Epub 2016 Dec 7.
4
Revised Estimates for the Number of Human and Bacteria Cells in the Body.人体和细菌细胞数量的修订估计值。
PLoS Biol. 2016 Aug 19;14(8):e1002533. doi: 10.1371/journal.pbio.1002533. eCollection 2016 Aug.
5
Bifidobacteria and Butyrate-Producing Colon Bacteria: Importance and Strategies for Their Stimulation in the Human Gut.双歧杆菌与产丁酸结肠细菌:它们在人体肠道中的重要性及刺激策略
Front Microbiol. 2016 Jun 28;7:979. doi: 10.3389/fmicb.2016.00979. eCollection 2016.
6
Hospitalized Patients with Heart Failure and Common Bacterial Infections: A Nationwide Analysis of Concomitant Clostridium Difficile Infection Rates and In-Hospital Mortality.心力衰竭合并常见细菌感染的住院患者:全国范围内艰难梭菌合并感染率及住院死亡率分析
J Card Fail. 2016 Nov;22(11):891-900. doi: 10.1016/j.cardfail.2016.06.005. Epub 2016 Jun 16.
7
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.2016欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南:欧洲心脏病学会(ESC)急性和慢性心力衰竭诊断与治疗工作组编写,欧洲心脏病学会心力衰竭协会(HFA)提供特别贡献。
Eur Heart J. 2016 Jul 14;37(27):2129-2200. doi: 10.1093/eurheartj/ehw128. Epub 2016 May 20.
8
Increasing Regulatory T Cells With Interleukin-2 and Interleukin-2 Antibody Complexes Attenuates Lung Inflammation and Heart Failure Progression.利用白细胞介素-2和白细胞介素-2抗体复合物增加调节性T细胞可减轻肺部炎症和心力衰竭进展。
Hypertension. 2016 Jul;68(1):114-22. doi: 10.1161/HYPERTENSIONAHA.116.07084. Epub 2016 May 9.
9
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity.基于人群的宏基因组学分析揭示了肠道微生物组组成和多样性的标志物。
Science. 2016 Apr 29;352(6285):565-9. doi: 10.1126/science.aad3369. Epub 2016 Apr 28.
10
Exploring the Microbiome in Heart Failure.探索心力衰竭中的微生物群。
Curr Heart Fail Rep. 2016 Apr;13(2):103-9. doi: 10.1007/s11897-016-0285-9.